We established a mouse model of developmental nonalcoholic steatohepatitis (NASH) by feeding a high polyunsaturated fat liquid diet to female glutathione-S-transferase 4-4 (Gsta4 À/À )/peroxisome proliferator activated receptor a (Ppara À/À ) double knockout 129/SvJ mice for 12 weeks from weaning. We used it to probe the importance of lipid peroxidation in progression of NASH beyond simple steatosis. Feeding Gsta4 À/À /Ppara À/À double-knockout (dKO) mice liquid diets containing corn oil resulted in a percentage fatedependent increase in steatosis and necroinflammatory injury (P < 0.05). Increasing fat to 70% from 35% resulted in increases in formation of 4-hydroxynonenal protein adducts accompanied by evidence of stellate cell activation, matrix remodeling, and fibrosis (P < 0.05). Comparison of dKO mice with wild-type (Wt) and single knockout mice revealed additive effects of Gsta4 À/À and Ppara À/À silencing on steatosis, 4-hydroxynonenal adduct formation, oxidative stress, serum alanine amino transferase, expression of tumor necrosis factor alpha, Il6, interferon mRNA, and liver pathology (P < 0.05). Induction of Cyp2e1 protein by high-fat diet was suppressed in Gsta4 À/À and dKO groups (P < 0.05). The dKO mice had similar levels of markers of stellate cell activation and matrix remodeling as Ppara À/À single KO mice. These data suggest that lipid peroxidation products play a role in progression of liver injury to steatohepatitis in NASH produced by high-fat feeding during development but appear less important in development of fibrosis. Pediatric nonalcoholic fatty liver disease is a prevalent chronic liver pathology observed in 9.6% of children and up to 38% of those that are obese.1 Fatty liver disease has been reported in morbidly obese children as young as 2 to 3 years old.1,2 In approximately 30% of cases, pediatric liver pathology progresses from simple steatosis to nonalcoholic steatohepatitis (pNASH), characterized by necroinflammation and development of fibrosis.3 pNASH is now the major cause of liver transplant in pediatric populations. 4 However, despite the emergence of pNASH as a major pediatric disease, little is known regarding the molecular mechanisms underlying the development of NASH in children and there are no good developmental animal models that mimic the natural etiological setting in which pNASH develops clinically.A nutritional model of adult NASH was developed in Sprague-Dawley rats by Lieber et al, 5 in which liver pathology developed after feeding a 71% high-fat liquid diet. This high-fat feeding model was also applied to adult mice lacking the transcription factor peroxisome